Bioventix (LON:BVXP) Announces Quarterly Earnings Results

Bioventix (LON:BVXP) announced its quarterly earnings results on Monday. The biotechnology company reported GBX 72.27 ($0.93) earnings per share for the quarter, Digital Look Earnings reports. Bioventix had a net margin of 59.51% and a return on equity of 69.09%.

Bioventix Trading Down 11.1 %

Shares of Bioventix stock traded down GBX 306 ($3.96) on Monday, hitting GBX 2,444 ($31.60). The stock had a trading volume of 21,228 shares, compared to its average volume of 5,672. The company’s 50 day moving average price is GBX 2,908.58 and its 200 day moving average price is GBX 3,367.22. The stock has a market cap of £127.98 million, a price-to-earnings ratio of 15.81 and a beta of 0.35. Bioventix has a 52-week low of GBX 2,400 ($31.03) and a 52-week high of GBX 4,800 ($62.06).

About Bioventix

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.